M.-C. Andry

747 total citations
26 papers, 611 citations indexed

About

M.-C. Andry is a scholar working on Pharmaceutical Science, Biomaterials and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M.-C. Andry has authored 26 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 8 papers in Biomaterials and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M.-C. Andry's work include Advanced Drug Delivery Systems (7 papers), Lanthanide and Transition Metal Complexes (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). M.-C. Andry is often cited by papers focused on Advanced Drug Delivery Systems (7 papers), Lanthanide and Transition Metal Complexes (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). M.-C. Andry collaborates with scholars based in France, Belgium and Switzerland. M.-C. Andry's co-authors include M.-C. Lévy, Florence Edwards‐Lévy, Gaëlle Roullin, Françoise Chuburu, Michaël Molinari, Cyril Cadiou, Sophie Laurent, Maïté Callewaert, Robert N. Müller and Luce Vander Elst and has published in prestigious journals such as Angewandte Chemie International Edition, International Journal of Pharmaceutics and Nanotechnology.

In The Last Decade

M.-C. Andry

26 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.-C. Andry France 16 228 210 190 107 94 26 611
Xiaoyan Bao China 17 269 1.2× 174 0.8× 297 1.6× 121 1.1× 122 1.3× 38 912
Maïté Callewaert France 14 192 0.8× 194 0.9× 176 0.9× 49 0.5× 94 1.0× 29 547
Otilia Koo United States 11 184 0.8× 403 1.9× 260 1.4× 208 1.9× 32 0.3× 16 882
Tilahun Ayane Debele Taiwan 14 185 0.8× 389 1.9× 418 2.2× 112 1.0× 27 0.3× 22 926
Nathan R. B. Boase Australia 15 193 0.8× 204 1.0× 193 1.0× 50 0.5× 96 1.0× 35 740
Guangyue Zu China 15 182 0.8× 236 1.1× 227 1.2× 54 0.5× 34 0.4× 33 636
Jun F. Liang United States 17 97 0.4× 238 1.1× 187 1.0× 111 1.0× 56 0.6× 31 830
Ellina A. Mun Kazakhstan 11 93 0.4× 160 0.8× 127 0.7× 200 1.9× 39 0.4× 19 560
Nir Debotton Israel 7 142 0.6× 284 1.4× 159 0.8× 123 1.1× 22 0.2× 10 642
Diti Desai Finland 17 213 0.9× 290 1.4× 328 1.7× 84 0.8× 29 0.3× 28 796

Countries citing papers authored by M.-C. Andry

Since Specialization
Citations

This map shows the geographic impact of M.-C. Andry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.-C. Andry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.-C. Andry more than expected).

Fields of papers citing papers by M.-C. Andry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.-C. Andry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.-C. Andry. The network helps show where M.-C. Andry may publish in the future.

Co-authorship network of co-authors of M.-C. Andry

This figure shows the co-authorship network connecting the top 25 collaborators of M.-C. Andry. A scholar is included among the top collaborators of M.-C. Andry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.-C. Andry. M.-C. Andry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Callewaert, Maïté, Laurence Van Gulick, Gaëlle Roullin, et al.. (2019). Evaluation of mTHPC-loaded PLGA nanoparticles for in vitro photodynamic therapy on C6 glioma cell line. Photodiagnosis and Photodynamic Therapy. 25. 448–455. 23 indexed citations
2.
3.
Roullin, Gaëlle, et al.. (2014). 腫瘍の長期間検出のためのポリ(ラクチド-co-グリコリド)に載せた新しい磁気共鳴画像化コントラスト剤. Nanotechnology. 25(44). 1–11. 27 indexed citations
4.
Roullin, Gaëlle, Juliette Moreau, Laurence Van Gulick, et al.. (2014). Encapsulated Ruthenium(II) Complexes in Biocompatible Poly(d,l‐lactide‐co‐glycolide) Nanoparticles for Application in Photodynamic Therapy. ChemPlusChem. 79(1). 171–180. 42 indexed citations
5.
Callewaert, Maïté, Gaëlle Roullin, Cyril Cadiou, et al.. (2014). Tuning the composition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T1/T2 MRI contrast agents. Journal of Materials Chemistry B. 2(37). 6397–6405. 35 indexed citations
6.
Roullin, Gaëlle, Cyril Cadiou, Christophe Portefaix, et al.. (2014). A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors. Nanotechnology. 25(44). 445103–445103. 15 indexed citations
7.
Courant, Thomas, Gaëlle Roullin, Cyril Cadiou, et al.. (2013). Biocompatible nanoparticles and gadolinium complexes for MRI applications. Comptes Rendus Chimie. 16(6). 531–539. 10 indexed citations
8.
Courant, Thomas, Gaëlle Roullin, Cyril Cadiou, et al.. (2012). Hydrogels Incorporating GdDOTA: Towards Highly Efficient Dual T1/T2 MRI Contrast Agents. Angewandte Chemie International Edition. 51(36). 9119–9122. 143 indexed citations
9.
Courant, Thomas, Gaëlle Roullin, Cyril Cadiou, et al.. (2012). Hydrogels Incorporating GdDOTA: Towards Highly Efficient Dual T1/T2 MRI Contrast Agents. Angewandte Chemie. 124(36). 9253–9256. 4 indexed citations
10.
Courant, Thomas, Gaëlle Roullin, Cyril Cadiou, et al.. (2010). Vectorization of copper complexes via biocompatible and biodegradable PLGA nanoparticles. Nanotechnology. 21(16). 165101–165101. 5 indexed citations
11.
Gatouillat, Grégory, et al.. (2009). In vivo anti-melanoma activities of the Melan-A/MART-1101–115 T CD4+ cell peptide. Vaccine. 27(44). 6107–6109. 3 indexed citations
12.
Courant, Thomas, Gaëlle Roullin, Cyril Cadiou, et al.. (2009). Development and physicochemical characterization of copper complexes-loaded PLGA nanoparticles. International Journal of Pharmaceutics. 379(2). 226–234. 13 indexed citations
13.
Gatouillat, Grégory, et al.. (2007). Enhanced immune response induced by BSA loaded in hydroxyethylstarch microparticles. International Journal of Pharmaceutics. 353(1-2). 131–138. 22 indexed citations
14.
Devy, Jérôme, et al.. (2005). Hydroxyethylstarch microcapsules: A preliminary study for tumor immunotherapy application. International Journal of Pharmaceutics. 307(2). 194–200. 20 indexed citations
15.
Edwards‐Lévy, Florence, et al.. (2002). Cross-linked β-cyclodextrin microcapsules. II. Retarding effect on drug release through semi-permeable membranes. International Journal of Pharmaceutics. 232(1-2). 175–181. 36 indexed citations
16.
Edwards‐Lévy, Florence, et al.. (2000). Cross-linked β-cyclodextrin microcapsules: preparation and properties. International Journal of Pharmaceutics. 211(1-2). 19–27. 38 indexed citations
17.
Andry, M.-C., et al.. (1998). Proanthocyanidin microcapsules: preparation, properties and free radical scavenging activity. International Journal of Pharmaceutics. 171(2). 217–226. 12 indexed citations
18.
Andry, M.-C., Florence Edwards‐Lévy, & M.-C. Lévy. (1996). Free amino group content of serum albumin microcapsules. III. A study at low pH values. International Journal of Pharmaceutics. 128(1-2). 197–202. 19 indexed citations
19.
Andry, M.-C., et al.. (1994). Polyhydroxamic microcapsules prepared from proteins: A novel type of chelating microcapsules. Journal of Microencapsulation. 11(2). 213–224. 4 indexed citations
20.
Lévy, M.-C. & M.-C. Andry. (1991). Mixed-walled microcapsules made of cross-linked proteins and polysaccharides: Preparation and properties. Journal of Microencapsulation. 8(3). 335–347. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyan Bao Breakdown of academic impact, for papers by Maïté Callewaert Breakdown of academic impact, for papers by Otilia Koo Breakdown of academic impact, for papers by Tilahun Ayane Debele Breakdown of academic impact, for papers by Nathan R. B. Boase Breakdown of academic impact, for papers by Guangyue Zu Breakdown of academic impact, for papers by Jun F. Liang Breakdown of academic impact, for papers by Ellina A. Mun Breakdown of academic impact, for papers by Nir Debotton Breakdown of academic impact, for papers by Diti Desai
Rankless by CCL
2026